Division of Hematology, Department of Medicine, Centre for Blood Research, University of British Columbia, Vancouver, British Columbia, Canada.
Curr Drug Targets. 2012 Mar;13(3):432-9. doi: 10.2174/138945012799424615.
CD248, also known as endosialin or tumor endothelial marker-1 (TEM-1), is a C-type lectin-like domain (CTLD) containing cell surface glycoprotein that is expressed by stromal cells of proliferating tissues during embryogenesis and postnatally in tumors and inflammatory lesions. Loss-of-function studies in mice support the notion that CD248 promotes tumor growth and inflammation, observations that are stimulating interest in evaluating this molecule as a therapeutic target. In spite of these advances, the mechanisms by which CD248 modulates cancer and inflammation remain largely enigmatic. This review highlights our current understanding of CD248, its structure, pattern of expression, regulation and function in various disease processes.
CD248,也称为内唾液酸或肿瘤内皮标志物-1(TEM-1),是一种含有 C 型凝集素样结构域(CTLD)的细胞表面糖蛋白,在胚胎发生和出生后的增殖组织的基质细胞中表达,在肿瘤和炎症病变中也表达。在小鼠中进行的功能丧失研究支持这样的观点,即 CD248 促进肿瘤生长和炎症,这些观察结果激发了人们对评估该分子作为治疗靶点的兴趣。尽管取得了这些进展,但 CD248 调节癌症和炎症的机制在很大程度上仍然是个谜。这篇综述强调了我们目前对 CD248 的理解,包括其结构、表达模式、调节和在各种疾病过程中的功能。